Article | May 1, 2023

Fixing The Regenerative Medicine Supply Chain

Source: X-Therma

By Arthi Shridhar


To keep up with demand, manufacturers face the difficult task of shortening the timeline between discovery and clinical implementation. The speed at which these therapies are developing and the corresponding cycle time for manufacture raises a host of supply chain struggles, beginning with the need to acquire stable and high-quality raw materials. To complicate the matter further, companies face labor challenges and the need for temperature-controlled distribution to ensure that final products are delivered in a safe and efficacious condition. What challenges do outdated cryopreservation techniques add for companies attempting to meet the growing demand for CGT therapies?


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene